Hu X H, Wu J, Lu S
Staff Room of Infectious Diseases, Guiyang Medical College, Guiyang 550004, China.
Zhonghua Yi Xue Za Zhi. 2017 Sep 19;97(35):2783-2788. doi: 10.3760/cma.j.issn.0376-2491.2017.35.016.
To investigate the interventional effect of Dan-fang capsule on liver fibrosis in rats. Sixty one-week aged male healthy SD rats [weight (180±20) g] were randomly divided into normal control group (group A), hepatic fibrosis model group (group B), Fu-Fang-Bie-Jia-Ruan-Gan tablet group (group C), Dan-fang capsule groups at high, middle and low dose group (group D, E, F, respectively). Except for the normal control group, hepatic fibrosis was induced in other groups by intraperitoneal injection of porcine serum.Simultaneously, rats in Dan-fang capsule groups were administered by gavage with Dan-fang capsule at doses of 4.32, 2.16, 0.54 g/kg, respectively.Rats in Fu-Fang-Bie-Jia-Ruan-Gan tablet group were orally administered by gavage with Fu-Fang-Bie-Jia-Ruan-Gan tablet (0.54 g/kg) every day and the normal control group received saline alone.All rats were killed at the end of the 12th week. Serum alanine aminotransferase (ALT), aspartate aminotransferase (AST) and PⅢnp clia (PⅢNP) were measured in the groups.Pathology changes of hepatic tissue were evaluated by hematoxylin-eosin (HE) and Masson staining.The proteinic expressions of alpha-smooth muscle actin (α-SMA), collagen-Ⅰ (COL-Ⅰ) and collagen-Ⅲ (COL-Ⅲ) were observed with the method of immunohistochemistry.Analysis of variance was applied when data were compared among groups. Compared with those in the group A, the levels of ALT, AST and PⅢNP in serum and the expressions of α-SMA, COL-Ⅰ and COL-Ⅲ in liver tissues were significantly higher in group B [(68.3±3.4) vs (51.5±6.3) U/L, (205±52) vs (135±24) U/L, (3.1±1.4) vs (1.6±0.6) μg/L and 0.35±0.02 vs 0.13±0.02, 0.37±0.02 vs 0.13±0.02, 0.43±0.13 vs 0.13±0.01, =17.020, 71.053, 1.552, 0.214, 0.241, 0.292, all <0.01], and the degree of liver fibrosis significantly increased in group B than that in group A. Compared with those in group B, the levels of ALT, AST, PⅢNP and the expressions of α-SMA, COL-Ⅰ, COL-Ⅲ were all significantly lower in group D, E and F (=-58.232--0.104, all <0.01). The degree of liver fibrosis significantly reduced in group D, E and F than that in group B (=3.82, 3.76, 3.90, all <0.05). Dan-fang capsule has certain preventive effect on liver fibrosis that caused by porcine serum in rats.
探讨丹方胶囊对大鼠肝纤维化的干预作用。将60只1周龄健康雄性SD大鼠[体重(180±20)g]随机分为正常对照组(A组)、肝纤维化模型组(B组)、复方鳖甲软肝片组(C组)、丹方胶囊高、中、低剂量组(D组、E组、F组)。除正常对照组外,其他组均腹腔注射猪血清诱导肝纤维化。同时,丹方胶囊组大鼠分别按4.32、2.16、0.54 g/kg剂量灌胃给予丹方胶囊。复方鳖甲软肝片组大鼠每天按0.54 g/kg剂量灌胃给予复方鳖甲软肝片,正常对照组仅给予生理盐水。所有大鼠在第12周结束时处死。检测各组血清丙氨酸氨基转移酶(ALT)、天冬氨酸氨基转移酶(AST)及Ⅲ型前胶原氨基端肽(PⅢNP)水平。采用苏木精-伊红(HE)染色和Masson染色评估肝组织病理变化。采用免疫组织化学方法观察α-平滑肌肌动蛋白(α-SMA)、Ⅰ型胶原(COL-Ⅰ)和Ⅲ型胶原(COL-Ⅲ)的蛋白表达。组间数据比较采用方差分析。与A组比较,B组血清ALT、AST、PⅢNP水平及肝组织α-SMA、COL-Ⅰ、COL-Ⅲ表达均显著升高[(68.3±3.4)比(51.5±6.3)U/L,(205±52)比(135±24)U/L,(3.1±1.4)比(1.6±0.6)μg/L,0.35±0.02比0.13±0.02,0.37±0.02比0.13±0.02,0.43±0.13比0.13±0.01,F=17.020、71.053、1.552、0.214、0.241、0.292,均P<0.01],且B组肝纤维化程度较A组显著加重。与B组比较,D组、E组、F组ALT、AST、PⅢNP水平及α-SMA、COL-Ⅰ、COL-Ⅲ表达均显著降低(F=-58.232~-0.104,均P<0.01)。D组、E组、F组肝纤维化程度较B组显著减轻(F=3.82、3.76、3.90,均P<0.05)。丹方胶囊对大鼠猪血清所致肝纤维化具有一定的预防作用。